- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
People
Luke Bosso is an associate in King & Spalding's Trial and Global Disputes group. His practice focuses on defending pharmaceutical, medical device, chemical, automotive, and product manufacturers in high-stakes mass tort and class action litigation. Luke leverages his background to help defend companies against technical and scientific issues surrounding product liability and toxic exposure claims. He is also a member of King & Spalding's LGBTQ+ affinity group and actively contributes to the firm’s diversity initiatives.
Luke earned his law degree from Georgetown University Law Center. While attending law school, Luke served as the Georgetown Editor-in-Chief of the Food and Drug Law Journal. He also practiced as a student attorney at Georgetown’s medical-legal partnership clinic and taught Street Law in D.C. Public Schools.
Prior to law school, Luke earned a Master of Sciences in Pharmacy, specializing in Pharmaceutical Outcomes and Policy, and a graduate certificate in Pharmaceutical Regulation.
Credentials
J.D., Georgetown University Law Center
M.S., University of Florida
B.A., University of Florida, summa cum laude, Phi Beta Kappa
Georgia
Insights
Client Alert
September 3, 2020
New FDA Guidance on Control of Nitrosamine Impurities
Insights
Client Alert
September 3, 2020
New FDA Guidance on Control of Nitrosamine Impurities
Credentials
J.D., Georgetown University Law Center
M.S., University of Florida
B.A., University of Florida, summa cum laude, Phi Beta Kappa
Georgia